Medications

The document reviewed various dermatological medications, detailing their mechanisms, uses, side effects, and interactions. It covered systemic immunosuppressants like prednisone, cytotoxic medications like methotrexate, and biologics such as TNF-α inhibitors (e.g., etanercept, adalimumab) for conditions like psoriasis and rheumatoid arthritis. It also discussed retinoids for severe acne and psoriasis, antibiotics, antifungals, antivirals, and other systemic and topical treatments. Specific medications for conditions like atopic dermatitis, actinic keratosis, and androgenetic alopecia, including minoxidil for hair growth, were highlighted. The document emphasized the importance of understanding drug interactions, side effects, and patient-specific factors to optimize dermatological care.